VIP-Producing Neuroendocrine Tumor — Trials

VIP-Producing Neuroendocrine Tumor — Trials · CancerIndex

Clinical trials

Registered studies

7 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04915144	177Lu-DOTATOC for the Treatment of Patients With Somatostatin Receptor Positive NETs	withdrawn	Phase 2	0	British Columbia Cancer AgencyOTHER	1	Feb 21, 2023	clinicaltrials
NCT02831179	Veliparib, Capecitabine, and Temozolomide in Patients With Advanced, Metastatic, and Recurrent Neuroendocrine Tumor	withdrawn	Phase 1	0	Vanderbilt-Ingram Cancer CenterOTHER	0	Sep 28, 2017	clinicaltrials

Data updated 22 days agoSource updated Feb 21, 2023source: clinicaltrials